{"altmetric_id":3731519,"counts":{"readers":{"mendeley":23,"citeulike":0,"connotea":0},"facebook":{"unique_users_count":1,"unique_users":["135034333239221"],"posts_count":1},"news":{"unique_users_count":1,"unique_users":["hal_archives_ouvertes"],"posts_count":1},"total":{"posts_count":5},"twitter":{"unique_users_count":2,"unique_users":["mrsawatch","mrsainfection"],"posts_count":3}},"selected_quotes":["In vitro activity of gentamicin, vancomycin or amikacin combined with EDTA or l-arginine as lock therapy against a\u2026","In vitro activity of gentamicin, vancomycin or amikacin combined with EDTA or l-arginine as lock therapy\u2026 #mrsa"],"citation":{"abstract":"Treatment of catheter-related bloodstream infections (CRBSI) is hampered by the characteristic tolerance of bacterial biofilms towards antibiotics. Our objective was to study the effect of the combination of antibiotics and the alkaline amino acid l-arginine or the cation chelator EDTA on the bacterial killing of in vitro biofilms formed by an array of clinical strains responsible for CRBSI and representative of epidemiologically relevant bacterial species.","abstract_source":"pubmed","altmetric_jid":"4f6fa4ee3cf058f610002c89","authors":["David Lebeaux","V\u00e9ronique Leflon-Guibout","Jean-Marc Ghigo","Christophe Beloin","Lebeaux D","Leflon-Guibout V","Ghigo JM","Beloin C"],"doi":"10.1093\/jac\/dkv044","first_seen_on":"2015-02-25T15:16:55+00:00","funders":["niehs"],"issns":["1460-2091","0305-7453"],"journal":"Journal of Antimicrobial Chemotherapy (JAC)","last_mentioned_on":1479726944,"links":["http:\/\/jac.oxfordjournals.org\/content\/early\/2015\/02\/23\/jac.dkv044.abstract?RESULTFORMAT=&andorexactfulltext=and&andorexacttitle=and&andorexacttitleabs=and&ct=&fulltext=MRSA&hits=13&maxtoshow=&resourcetype=HWCIT&searchid=1&usestrictdates=yes","http:\/\/jac.oxfordjournals.org\/content\/70\/6\/1704.abstract?RESULTFORMAT=&andorexactfulltext=and&andorexacttitle=and&andorexacttitleabs=and&ct=&fulltext=MRSA&hits=8&maxtoshow=&resourcetype=HWCIT&searchid=1&usestrictdates=yes","http:\/\/jac.oxfordjournals.org\/content\/70\/6\/1704.abstract","http:\/\/dx.doi.org\/10.1093\/jac\/dkv044"],"pdf_url":"http:\/\/jac.oxfordjournals.org\/content\/early\/2015\/02\/23\/jac.dkv044.full.pdf","pmid":"25712314","pubdate":"2015-06-01T00:00:00+00:00","publisher_subjects":[{"name":"Pharmacology And Pharmaceutical Sciences","scheme":"era"},{"name":"Microbiology","scheme":"era"},{"name":"Medical Microbiology","scheme":"era"}],"scopus_subjects":["Health Sciences","Medicine","Life Sciences","Pharmacology, Toxicology and Pharmaceutics"],"subjects":["drugtherapy"],"title":"In vitro activity of gentamicin, vancomycin or amikacin combined with EDTA or l-arginine as lock therapy against a wide spectrum of biofilm-forming clinical strains isolated from catheter-related infections","type":"article","mendeley_url":"http:\/\/www.mendeley.com\/research\/vitro-activity-gentamicin-vancomycin-amikacin-combined-edta-larginine-lock-therapy-against-wide-spec"},"altmetric_score":{"score":9.75,"score_history":{"1y":7,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":9.75},"context_for_score":{"all":{"total_number_of_other_articles":7722452,"mean":6.6241115612059,"rank":785160,"this_scored_higher_than_pct":89,"this_scored_higher_than":6931647,"rank_type":"exact","sample_size":7722452,"percentile":89},"similar_age_3m":{"total_number_of_other_articles":203042,"mean":9.0819410069889,"rank":29146,"this_scored_higher_than_pct":85,"this_scored_higher_than":173601,"rank_type":"exact","sample_size":203042,"percentile":85},"this_journal":{"total_number_of_other_articles":3200,"mean":5.17378243201,"rank":305,"this_scored_higher_than_pct":90,"this_scored_higher_than":2893,"rank_type":"exact","sample_size":3200,"percentile":90},"similar_age_this_journal_3m":{"total_number_of_other_articles":93,"mean":4.2640652173913,"rank":11,"this_scored_higher_than_pct":88,"this_scored_higher_than":82,"rank_type":"exact","sample_size":93,"percentile":88}}},"demographics":{"poster_types":{"member_of_the_public":2},"users":{"twitter":{"cohorts":{"Members of the public":2}},"mendeley":{"by_status":{"Professor > Associate Professor":2,"Researcher":7,"Student  > Doctoral Student":1,"Student  > Ph. D. Student":7,"Student  > Postgraduate":1,"Other":1,"Student  > Master":1,"Student  > Bachelor":3},"by_discipline":{"Materials Science":1,"Medicine and Dentistry":12,"Chemistry":2,"Agricultural and Biological Sciences":5,"Biochemistry, Genetics and Molecular Biology":2,"Pharmacology, Toxicology and Pharmaceutical Science":1}}},"geo":{"twitter":{"FR":1},"mendeley":{"DK":1,"ES":1}}},"posts":{"twitter":[{"url":"https:\/\/twitter.com\/mrsawatch\/status\/570603018342641664","license":"datasift","citation_ids":[3731519],"posted_on":"2015-02-25T15:15:35+00:00","author":{"name":"MRSA Watch","url":"http:\/\/tahilla.typepad.com\/mrsawatch","image":"https:\/\/pbs.twimg.com\/profile_images\/1222035691\/MRSA_9_normal.jpg","description":"MRSA News","id_on_source":"mrsawatch","tweeter_id":"41137185","geo":{"lt":48.85341,"ln":2.3488,"country":"FR"},"followers":1128},"tweet_id":"570603018342641664"},{"url":"https:\/\/twitter.com\/mrsainfection\/status\/603881162965024768","license":"datasift","citation_ids":[3731519],"posted_on":"2015-05-28T11:11:03+00:00","author":{"name":"MRSA INFECTION","url":"http:\/\/www.mrsainfection.net","image":"https:\/\/pbs.twimg.com\/profile_images\/1222048374\/MRSA_6_normal.jpg","description":"MRSA Information","id_on_source":"mrsainfection","tweeter_id":"36626253","geo":{"lt":null,"ln":null},"followers":723},"tweet_id":"603881162965024768"},{"url":"https:\/\/twitter.com\/mrsawatch\/status\/603881044530483201","license":"datasift","citation_ids":[3731519],"posted_on":"2015-05-28T11:10:35+00:00","author":{"name":"MRSA Watch","url":"http:\/\/tahilla.typepad.com\/mrsawatch","image":"https:\/\/pbs.twimg.com\/profile_images\/1222035691\/MRSA_9_normal.jpg","description":"MRSA News","id_on_source":"mrsawatch","tweeter_id":"41137185","geo":{"lt":48.85341,"ln":2.3488,"country":"FR"},"followers":1128},"tweet_id":"603881044530483201"}],"facebook":[{"title":"In vitro activity of gentamicin, vancomycin or amikacin combined with EDTA or l-arginine as lock...","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=847750245300956&id=135034333239221","license":"public","citation_ids":[3731519],"posted_on":"2015-06-04T15:59:00+00:00","summary":"\u0650Addition of EDTA enhanced the activity of gentamicin, amikacin and vancomycin against biofilms by a wide spectrum of bacterial strains responsible for CRBSI. \n___________________________________________________\n\n\nObjectives Treatment of catheter-related b","author":{"name":"Drug information","url":"https:\/\/www.facebook.com\/135034333239221","facebook_wall_name":"Drug information","image":"https:\/\/graph.facebook.com\/135034333239221\/picture","id_on_source":"135034333239221"}}],"news":[{"title":"David Lebeaux, V\u00e9ronique Leflon-Guibout, Jean-Marc Ghigo, Christophe Beloin. In vitro activity of gentamicin, vancomycin or amikacin combined with EDTA or l-arginine as lock therapy against a wide spectrum of biofilm-forming clinical strains isolated from","url":"http:\/\/ct.moreover.com\/?a=28675111842&p=1pl&v=1&x=E_eYM0TV6qBXM4WJ-FdHGQ","license":"public","citation_ids":[3731519],"posted_on":"2016-11-21T11:15:44+00:00","summary":"David Lebeaux, V\u00e9ronique Leflon-Guibout, Jean-Marc Ghigo, Christophe Beloin. In vitro activity of gentamicin, vancomycin or amikacin combined with EDTA or l-arginine as lock therapy against a wide spectrum of biofilm-forming clinical strains\u2026","author":{"name":"HAL Archives-Ouvertes","url":"https:\/\/hal.archives-ouvertes.fr\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/679\/normal\/Screen_Shot_2016-01-26_at_14.14.52.png?1453817707"}}]}}